Abstract
Background: The pyruvate dehydrogenase (PDH) complex is essential in the glycolytic conversion of pyruvate to acetyl-CoA. This reaction helps yield adenosine triphosphate (ATP) – a source for energy. Hence, PDH deficiency will lead to metabolic dysfunction. Case: The case report at hand unearths the perplexing presentation of two genetically predisposed Emirati siblings that were found to be thiamine responsive. Both patients complained of a variety of symptoms at the same age following an episode of gastritis. They undergo extensive laboratory tests and imaging and are initially diagnosed with non-alcoholic Wernicke encephalopathy (WE). Objective: It has come to our attention that this rapidly debilitating condition demonstrates a constellation of seemingly incongruent gastrointestinal and neuropsychiatric manifestations. It is imperative that the peculiarities of this disease be recognized. Because PDH deficiency does not conform to defined diagnostic criteria outlined in evidence-based guidelines, treatment is likely to be delayed. Method: A careful retrospective scrutiny of the patients’ initial presentation and peculiar hospital course encourages identification of our limitations in providing efficacious quality care and in hopes of devising a systematic approach for future encounters. Conclusion: Any patient presenting to the emergency department with prolonged vomiting or diarrhea, for example, should be given thiamine as it is safe, inexpensive and may be lifesaving. We herein report two patients with indistinct, yet similar, signs and symptoms.
Highlights
The PDHA1 and PHDB genes produce proteins that combine to form the enzyme pyruvate dehydrogenase (PDH) [1]
PDH deficiency is perilous as it remains underdiagnosed among children on a global scale
The present study highlights the challenges encountered with PDH deficiency patients in terms of deciphering an ambiguous presentation, distinguishing it from suspected
Summary
The PDHA1 and PHDB genes produce proteins that combine to form the enzyme PDH [1]. A mutation of either gene results in reduced PDH activity, subsequent lactic acidosis and hyperpyruvatemia [1]. The clinical features of PDH deficiency are more inclined to appear [3]. This concept can be applied to cases of WE. The present study highlights the challenges encountered with PDH deficiency patients in terms of deciphering an ambiguous presentation, distinguishing it from suspected. Deficiency: Combined Case Studies acute non-alcoholic WE, preventing deleterious progression and, lastly, formation of a clinical roadmap that tackles disease
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
